Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.

Frontiers in immunology - 1 Jan 2020

Pilon Caroline, Bigot Jeremy, Grondin Cynthia, Thiolat Allan, Lang Philippe, Cohen José L, Grimbert Philippe, Matignon Marie

Abstract excerpt

High dose intravenous immunoglobulin (IVIG) are widely used after kidney transplantation and its biological effect on T and B cell phenotype in the context of maintenance immunosuppression was not documented yet. We designed a monocentric prospective cohort study of kidney allograft recipients with anti-HLA donor specific antibodies (DSA) without acute rejection on screening biopsies treated with prophylactic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allografts
Share to Graft Rejection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft Survival

Share to Immunization, Passive

Share to Immunoglobulins, Intravenous

Share to Tissue Donors

Share to Transplant Recipients

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 32038663
DOI: 10.3389/fimmu.2020.00034
PMCID: PMC6993066

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.PMID 32038663Read ↗

Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids.Semantic proximity Read ↗

Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Semantic proximity Read ↗

Successful eculizumab treatment as an adjunctive therapy to desensitization in ABO-incompatible living donor kidney transplantation and its molecular phenotypes.Semantic proximity Read ↗

Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients.Semantic proximity Read ↗

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.Semantic proximity Read ↗

Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney TransplantSemantic proximity Read ↗

Immune Cell Infiltration is Discriminative for ABMR and TCMRSemantic proximity Read ↗

Treatment of Chronic Active Antibody-mediated Rejection in Renal Transplant Recipients – A single center retrospective studySemantic proximity Read ↗

Single-Cell RNA Sequencing Reveals the Immunological Profiles of Renal Allograft Rejection in Mice.Semantic proximity Read ↗

Gene expression profile of human T cells following a single stimulation of peripheral blood mononuclear cells with anti-CD3 antibodiesSemantic proximity Read ↗

Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury.Semantic proximity Read ↗

Regulatory B cells: the cutting edge of immune tolerance in kidney transplantationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.